RNTX
Rein Therapeutics Inc.
NASDAQHealthcareMedical - PharmaceuticalsUS
Rating:C
Company Profile
CEO
James Brian Windsor
IPO Date
2017-06-29
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ
Country
US
Rein Therapeutics Inc.
CEO
James Brian Windsor
IPO Date
2017-06-29
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ
Country
US
| 3,420 |
| $1.04 |
| 28 May 2026 | VON RICKENBACH JOSEF H | director | P-Purchase | Acquired | 15,950 | $1.05 |
| 28 May 2026 | VON RICKENBACH JOSEF H | director | P-Purchase | Acquired | 23,190 | $1.06 |
| 13 May 2026 | WINDSOR JAMES BRIAN | director, officer: See Remarks | P-Purchase | Acquired | 25,000 | $1.00 |
| 13 May 2026 | WINDSOR JAMES BRIAN | director, officer: See Remarks | A-Award | Disposed | 150,000 | $1.17 |
| 18 Nov 2025 | Voss Capital, LP | 10 percent owner | P-Purchase | Acquired | 104,183 | $1.22 |
| 28 Oct 2025 | Voss Capital, LP | 10 percent owner | P-Purchase | Acquired | 30,176 | $1.39 |
| 28 Oct 2025 | Voss Capital, LP | 10 percent owner | P-Purchase | Acquired | 92,642 | $1.37 |
| 28 Oct 2025 | Voss Capital, LP | 10 percent owner | P-Purchase | Acquired | 4,840 | $1.37 |